Atlas Trials

Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19

Clinical trial NCT04871776 · COMPLETED

Trial details

NCT number
NCT04871776
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid19Vaccine Refusal
Start date
2022-02-18
Primary completion
2022-05-27
Enrollment
3671

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.